How to get the most of out of your UAT process and focus your efforts where they should be.
The special requirements that must be met as the cloud as adopted by life sciences organizations.
How to be sure that the solution you’ve chosen is best suited to completing this task with speed and ease.
What can be done to that the technology opening new doors in the capture and analysis of clinical data, and the guidance responsible for regulating them, keep up with one another?
In addition to careful adherence with all applicable regulatory and Customs requirements, sponsors should understand and be sensitive to the cultural and business norms of each country included in their study.
Selecting a partner is challenging, but with the right information you can simplify your efforts and increase your likelihood of making the best decision.
Although there are clear benefits with the first pill to include a digital sensor that tracks if and when it has been ingested brings, there are also questions regarding patient privacy and choice.
Improving outcomes in clinical trials and reducing the trend toward high placebo response across different therapeutic areas requires the involvement of multiple stakeholders.
In this paper, some of our thought-leaders provide their insights on what they are watching for and what they anticipate in 2018 in clinical trial technology, regulatory changes, and scientific developments.
This article discusses best practices for developing and implementing a patient-centered approach to Alzheimer’s Disease clinical research. Using the right channels and messaging to speed recruitment and provide lasting engagement can improve study success rates.
|
|
|
|
|
|
|
|
|